Keywords: ARCON; accelerated radiotherapy with carbogen and nicotinamide; cAMP; cyclic adenosine monophosphate; CA4P; combretastatin A-4 phosphate; CAIX; carbonic anhydrase IX; CNS; central nervous system; CT; computed tomography; CTLA4; cytotoxic T-lymphocyte asso
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Effects of combretastatin A-4 phosphate on canine normal and tumor tissue-derived endothelial cells
Keywords: Combretastatin A-4 phosphate; Endothelial cells; Canine; Tumor; VE-cadherin;
Exaggerated hypertensive response to combretastatin A-4 phosphate in hypertensive rats: Effective pharmacological inhibition by diltiazem
Keywords: ACEI; angiotensin converting enzyme inhibitor; CA4P; Combretastatin A-4 phosphate; DSS; Dahl salt sensitive; HS; high salt; MAP; mean arterial blood pressure; ND; normal low salt diet; Anticancer agents; Blood pressure; Calcium channel blockers; Cardiac t
The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts
Keywords: ANOVA; analysis of variance; BLI; bioluminescence imaging; CA4; combretastatin A-4; CA4P; combretastatin A-4 phosphate; DAPI; 4â²,6-diamidino-2-phenylindole; DMSO; dimethyl sulfoxide; DTT; dithiothreitol; FAK; focal adhesion kinase; FDA; Federal Drug Adm
The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents
Keywords: CA-4P; combretastatin A-4 phosphate; VEGFR-2; vascular endothelial growth factor receptor-2; RTKs; receptor tyrosine kinases; 2ME2; 2-methoxyestradiol; PDGFR-β; platelet-derived growth factor receptor β; CAM; chorioallantoic membrane; DDQ; 2,3-dichloro-
Diffusion-Weighted Magnetic Resonance Imaging Allows Noninvasive In Vivo Monitoring of the Effects of Combretastatin A-4 Phosphate after Repeated Administration
Keywords: vascular targeting; anticancer therapy; DW-MRI; necrosis; CA4-P; ADC; apparent diffusion coefficient; CA-4-P; combretastatin A-4 phosphate; DCE-MRI; dynamic contrast-enhanced magnetic resonance imaging; DW-MRI; diffusionweighted magnetic resonance imaging